Literature DB >> 1647770

C-type natriuretic peptide is a growth inhibitor of rat vascular smooth muscle cells.

M Furuya1, M Yoshida, Y Hayashi, N Ohnuma, N Minamino, K Kangawa, H Matsuo.   

Abstract

C-type natriuretic peptide (CNP) which potently stimulates particulate guanylate cyclase activity in cultured rat vascular smooth muscle cells (VSMC) inhibited serum-induced DNA synthesis of the cells 10-fold more effectively than alpha-human atrial natriuretic peptide (alpha-hANP). The inhibitory effect of CNP was mimicked by 8-bromo-cGMP. The proliferation of VSMC was also suppressed by CNP more potently than alpha-hANP, while the peptide was less active for cGMP augmentation and for vasorelaxation than alpha-hANP in isolated rat aorta. These results suggest that CNP may be a growth regulating factor of VSMC rather than a vasodilator.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1647770     DOI: 10.1016/0006-291x(91)90627-j

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  33 in total

1.  Glycosylation of asparagine 24 of the natriuretic peptide receptor-B is crucial for the formation of a competent ligand binding domain.

Authors:  R Fenrick; N Bouchard; N McNicoll; A De Léan
Journal:  Mol Cell Biochem       Date:  1997-08       Impact factor: 3.396

2.  Expression of B-type natriuretic peptide in atrial natriuretic peptide gene disrupted mice.

Authors:  M Y Tse; J D Watson; I R Sarda; T G Flynn; S C Pang
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

3.  In vivo Evaluation of Cenderitide-Eluting Stent (CES) II.

Authors:  Yingying Huang; Xu Wen Ng; Soon Ghim Lim; Horng Haur Chen; John C Burnett; Yin Chiang Freddy Boey; Subbu S Venkatraman
Journal:  Ann Biomed Eng       Date:  2015-07-16       Impact factor: 3.934

Review 4.  The renin-angiotensin-aldosterone system and the cardiac natriuretic peptides.

Authors:  A M Richards
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

5.  Paracrine effect of human vascular endothelial cells on human vascular smooth muscle cell proliferation: transmembrane co-culture method.

Authors:  H Yoshida; M Nakamura; S Makita; K Hiramori
Journal:  Heart Vessels       Date:  1996       Impact factor: 2.037

6.  Circulating C-type natriuretic peptide and its relationship to cardiovascular disease in the general population.

Authors:  S Jeson Sangaralingham; Paul M McKie; Tomoko Ichiki; Christopher G Scott; Denise M Heublein; Horng H Chen; Kent R Bailey; Margaret M Redfield; Richard J Rodeheffer; John C Burnett
Journal:  Hypertension       Date:  2015-04-20       Impact factor: 10.190

Review 7.  Central role of guanylyl cyclase in natriuretic peptide signaling in hypertension and metabolic syndrome.

Authors:  G Martel; P Hamet; Johanne Tremblay
Journal:  Mol Cell Biochem       Date:  2009-11-25       Impact factor: 3.396

8.  Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor.

Authors:  Sharmila D Chauhan; Holger Nilsson; Amrita Ahluwalia; Adrian J Hobbs
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

9.  Expression and differential regulation of natriuretic peptides in mouse macrophages.

Authors:  A M Vollmar; R Schulz
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

10.  Cloning and functional expression of the bovine natriuretic peptide receptor-B (natriuretic factor R1c subtype.

Authors:  R Fenrick; K Babinski; N McNicoll; M Therrien; J Drouin; A De Léan
Journal:  Mol Cell Biochem       Date:  1994-08-31       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.